Objects
Ribbons, Karen, Lea, Rodney, Schofield, Peter W., Lechner-Scott, Jeannette. American Psychiatric Publishing; 2017. Anxiety levels are independently associated with cognitive performance in an Australian multiple sclerosis patient cohort.
Ditton, Elizabeth, Johnson, Sarah, Hodyl, Nicolette, Flynn, Traci, Pollack, Michael, Ribbons, Karen, Walker, Frederick Rohan, Nilsson, Michael. Frontiers Research Foundation; 2020. Improving patient outcomes following total knee arthroplasty: identifying rehabilitation pathways based on modifiable psychological risk and resilience factors.
Al-iedani, Oun, Lechner-Scott, Jeannette, Ribbons, Karen, Ramadan, Saadallah. BioMed Central; 2017. Fast magnetic resonance spectroscopic imaging techniques in human brain-applications in multiple sclerosis.
ARM, Jameen, Ribbons, Karen, Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2019. Evaluation of MS related central fatigue using MR neuroimaging methods: scoping review.
Dunlop, Adrian J., Dunlop, AJ, Brown, AL, Oldmeadow, C, Attia, J, Harris, A, Ghijben, P, Sadler, C, Attia, J, Bell, J, Bell, J, Lintzeris, N, Brown, Amanda L., Hinman, Jennifer, Jackson, Melissa, Bell, James, Lintzeris, Nicholas, Oldmeadow, Christopher, Harris, Anthony, Gill, Anthony, Sadler, Craig, Ribbons, Karen, Attia, John, Barker, Daniel, Ghijben, Peter. Elsevier; 2017. Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial.
Al-iedani, Oun, Ribbons, Karen, Gholizadeh, Neda, Lechner-Scott, Jeanette, Quadrelli, Scott, Lea, Rodney, Andronesi, Ovidiu, Ramadan, Saadallah. Elsevier; 2020. Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients.
Lechner-Scott, Jeannette, Reeves, Penny, Ribbons, Karen, Saugbjerg, Bente, Lea, Rodney. CSIRO; 2021. Do people with multiple sclerosis receive appropriate support from the National Disability Insurance Scheme matching their level of disability? A description of disease 'burden and societal cost in people with multiple sclerosis in Australia' (BAC-MS).
Al-iedani, Oun, Arm, Jameen, Ribbons, Karen, Lea, Rodney L., Lechner-Scott, Jeannette, Ramadan, Saadallah. Elsevier; 2018. Diurnal stability and long-term repeatability of neurometabolites using single voxel 1H magnetic resonance spectroscopy.
Jameen, A. R. M., Al-iedani, Oun, Ribbons, Karen, Lea, Rod, Lechner-Scott, Jeannette, Ramadan, Saadallah. Wiley-Blackwell Publishing; 2021. Biochemical Correlations with Fatigue in Multiple Sclerosis Detected by MR 2D Localized Correlated Spectroscopy.
Arm, Jameen, Al-iedani, Oun, Quadrelli, Scott, Ribbons, Karen, Lea, Rod, Lechner-Scott, Jeanette, Ramadan, Saadallah. John Wiley & Sons; 2018. Reliability of neurometabolite detection with two-dimensional localized correlation spectroscopy at 3T.
Ribbons, Karen, Lea, Rodney, Tiedeman, Clare, Mackenzie, Laura, Lechner-Scott, Jeannette. Sage; 2017. Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 50-year study.
Maltby, Vicki E., Lea, Rodney A., Ribbons, Karen, Lea, Marino G., Schofield, Peter W., Lechner-Scott, Jeannette. Elsevier; 2020. Comparison of BICAMS and ARCS for assessment of cognition in multiple sclerosis and predictive value of employment status.
Quadrelli, Scott, Ribbons, Karen, Arm, Jameen, Al-iedani, Oun, Lechner-Scott, Jeannette, Lea, Rodney, Ramadan, Saadallah. Sage; 2019. 2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis.
Al-iedani, Oun, Lea, Rodney, Ribbons, Karen, Ramadan, Saadallah, Lechner-Scott, Jeannette. Wiley-Blackwell; 2022. Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy.
Hodyl, Nicolette, Mason, Gillian, Ribbons, Karen, Bailey, Lucy, O'Malley, Adrian, Ward, Tracy, Ward, Stephen, Pollack, Michael, Nilsson, Michael, Walker, Frederick Rohan. Wiley-Blackwell; 2024. Barriers and Enablers for Accessing Rehabilitation Services: Findings From the Rehabilitation Choices Study, Part 1—Healthcare Professionals' Perspectives.